These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26950287)

  • 1. The best allergen immunotherapy choice for mite allergic patients.
    Ciprandi G; Incorvaia C; Masieri S; Buttafava S; Frati F
    Expert Rev Clin Immunol; 2016 Jun; 12(6):603-4. PubMed ID: 26950287
    [No Abstract]   [Full Text] [Related]  

  • 2. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy.
    Takai T; Yokota T; Yasue M; Nishiyama C; Yuuki T; Mori A; Okudaira H; Okumura Y
    Nat Biotechnol; 1997 Aug; 15(8):754-8. PubMed ID: 9255789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
    Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
    Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin E-binding epitopes of mite allergens: from characterization to immunotherapy.
    Cui Y
    Clin Rev Allergy Immunol; 2014 Dec; 47(3):344-53. PubMed ID: 24218295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific immunoglobulin E and immunoglobulin G4 toward major allergens of house-dust mite during allergen-specific immunotherapy.
    Chen J; Zhou Y; Wang Y; Zheng Y; Lai X; Westermann-Clark E; Cho SH; Kong W
    Am J Rhinol Allergy; 2017 May; 31(3):156-160. PubMed ID: 28490399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [GUIDE TO ALLERGEN IMMUNOTHERAPY FOR MITE ALLERGY].
    Gotoh M
    Arerugi; 2017; 66(6):788-791. PubMed ID: 28701643
    [No Abstract]   [Full Text] [Related]  

  • 8. Mite allergens.
    Caraballo L
    Expert Rev Clin Immunol; 2017 Apr; 13(4):297-299. PubMed ID: 28162009
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy.
    Batard T; Baron-Bodo V; Martelet A; Le Mignon M; Lemoine P; Jain K; Mariano S; Horiot S; Chabre H; Harwanegg C; Marquette CA; Corgier BP; Soh WT; Satitsuksanoa P; Jacquet A; Chew FT; Nony E; Moingeon P
    Allergy; 2016 Feb; 71(2):220-9. PubMed ID: 26485347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen immunotherapy.
    Mannan S
    Immunotherapy; 2017 Nov; 9(15):1199-1200. PubMed ID: 29130796
    [No Abstract]   [Full Text] [Related]  

  • 11. Geography of house dust mite allergens.
    Thomas WR
    Asian Pac J Allergy Immunol; 2010 Dec; 28(4):211-24. PubMed ID: 21337903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of immunotherapy with individual allergens: Immunotherapy with fungi.
    Pineda F
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():36-38. PubMed ID: 29129403
    [No Abstract]   [Full Text] [Related]  

  • 13. Dusting off recombinant allergens.
    Marshall GD; Davis F
    Nat Biotechnol; 1997 Aug; 15(8):718-9. PubMed ID: 9255778
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic aspects in house dust mite allergy.
    Mosbech H
    Dan Med Bull; 1991 Oct; 38(5):390-400. PubMed ID: 1802624
    [No Abstract]   [Full Text] [Related]  

  • 15. Mite immunotherapy.
    Fernández-Caldas E; Iraola V; Boquete M; Nieto A; Casanovas M
    Curr Allergy Asthma Rep; 2006 Sep; 6(5):413-9. PubMed ID: 16899204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen immunotherapy in atopic dermatitis.
    Ridolo E; Martignago I; Riario-Sforza GG; Incorvaia C
    Expert Rev Clin Immunol; 2018 Jan; 14(1):61-68. PubMed ID: 29110542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in immunotherapy for allergic diseases.
    El-Qutob D; Mencia G; Fernandez-Caldas E
    Recent Pat Inflamm Allergy Drug Discov; 2014 Jan; 8(1):24-35. PubMed ID: 24237114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in allergen-specific IgG-4 during desensitization of patients with hay fever and those sensitized to housedust allergens].
    Kruszewski J
    Pneumonol Alergol Pol; 1991; 59 Suppl 1():31-9. PubMed ID: 1843806
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of purified Dermatophagoides pteronyssinus allergens and extract by two-dimensional immunoblotting and quantitative immunoglobulin E inhibitions.
    Weghofer M; Thomas WR; Pittner G; Horak F; Valenta R; Vrtala S
    Clin Exp Allergy; 2005 Oct; 35(10):1384-91. PubMed ID: 16238800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of house dust mite-allergic patients by molecular diagnosis may enhance success of specific immunotherapy.
    Chen KW; Zieglmayer P; Zieglmayer R; Lemell P; Horak F; Bunu CP; Valenta R; Vrtala S
    J Allergy Clin Immunol; 2019 Mar; 143(3):1248-1252.e12. PubMed ID: 30445063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.